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Meeting Report
The Third United StatesJapan Meeting on
the Toxicological Characterization of
Environmental Chemicals'
byYuji Kurokawa2 and Terri Damstra3
This reportsummarizes the discussion ofthe Third U.S.-Japan Meetingon the Toxicological Characteriza-
tion of Environmental Chemicals held under the auspices of the U.S.-Japan cooperative in research and
development in science and technology. Recent data on the interrelationships between toxicity, cell prolifera-
tion, and carcinogenicity are presented.
Introduction
The third joint meeting between scientists from the
National Institute of Environmental Health Sciences
(NIEHS), Research Tliangle Park, North Carolina, and
the National Institute of Hygienic Sciences (NIHS),
Tokyo, Japan, washeldFebruary4-6,1991.The purposeof
these meetings, held under the auspices ofthe U.S.-Japan
Agreement on Cooperation in Research and Development
in Science and Technology, is to exchange information on
the toxicological characterization ofenvironmental chemi-
cals of mutual interest (1,2). The emphasis of this third
meeting was on theinterrelationship between toxicity, cell
proliferation, and carcinogenicity and on mid-term assays
and assays for initiation and promoting activities.
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Evaluation of Chronic Carcinogenicity
in Rodents
The first part ofthe meeting focused on the strengths
and weaknesses of the 2-year chronic carcinogenicity
tests in rats and mice. Meeting participants discussed
several ofthe recent criticisms made byAmes et al. (3) on
the scientific value of long-term chemical carcinogenesis
experiments inlaboratoryanimals asreliablepredictors of
human cancer risk. These authors assert that testing
chemicalsforcarcinogenicityathigh(maximumtolerated)
doses in rodents does notprovide adequateinformation to
predict the excess numbers ofhuman cancers that might
occur at low-dose exposures. Ames et al. contend that
testing at the maximum tolerated dose can cause chronic
cell injury, resulting in increased cell proliferation, which
mayultimately result in carcinogenesis (4). These authors
consideragents thatcause cellproliferation tobethe most
numerous and important class ofhuman carcinogens and
argue that many chemicals that cause increases in tumor
incidence in rodents do so because they are toxic at the
maximum tolerated dose. Thus, the risks from exposures
tolowerlevelsinhumansisgreatlyexaggerated, andmany
chemicals are being falsely identified as carcinogens.
However, anumberofstudies (5-10) offerlittle evidence
to support this theory. An analysis of the U.S. National
Toxicology Program (NTP) database (nearly 400 long-
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view that carcinogenesis mechanisms at high exposure
levels produce results notfound atlowerlevels (11). In 75%
of the rat studies (50% of the mouse studies) in which
chronic liver toxicitywas observed, there was not a corre-
sponding increase in the incidence of liver tumors. Simi-
larly, ethyl acrylate, administered by gavage to F344 rats
for 14 days, produced cell proliferation, hyperkeratosis,
ulceration, and inflammation ofthe forestomach; however,
whenthiscompoundwas administeredtoratsfor13weeks
andthe animalswereheldfor22months, theforestomachs
appeared normal. Evidently, the forestomach lesions pro-
ducedafter13weeksofexposuretoethylacrylatewerenot
sufficient to elicit a carcinogenic response. An analysis of
existingdatashowsthatsomechemicals caninducecancer
without sighificant toxic effects and cellular proliferation,
whereas others induce toxicity and cellular proliferation
withoutinducing cancer (12). Unless itcan be shown more
definitively thatenhanced cellproliferation resulting from
exposure to nongenotoxic carcinogens is responsible for
their carcinogenicity, itis inappropriate to overemphasize
the use ofcellproliferation dataintherisk assessment for
human cancer. Procedures used to extrapolate animal
carcinogenicity data to human risks from exposure to
lower doses of nongenotoxic chemicals should not be
amended until the carcinogenic mechanisms ofthese com-
pounds are more clearly understood.
The experimental design (duration and frequency of
dosing) of carcinogenicity studies was also discussed. In
the NTP, rats and mice are exposed for 2 years. The
guidelines of the Organization for Economic Cooperation
and Development (OECD), the Environmental Protection
Agency (EPA), and Japan recommend 2 years in rats, and
1.5 years or more in mice. A 1-3 month recovery or
withdrawal period after 2-year treatment is also recom-
mended in the Japanese guidelines. During this with-
drawal period, a nonneoplastic hyperplasia related to
treatment may regress, whereas hyperplasia regarded as
preneoplasticwillpersist. Forextremelytoxicchemicals, it
maybe difficult to expose at high doses for 2 years due to
high mortality. To address this problem, Japanese scien-
tistsproposeda"discontinuedprotocol" design,whichwas
used in the induction of renal cell tumors in rats by
potassium bromate (13) and of liver and urinary bladder
tumors by2-acetylaminofluorene (14). In bothinstances, a
higher dose given for a shorter period of time induced
more tumors than a lower dose given for a longer period.
Participants concludedthattheduration/frequency/rate of
dosing needs to be evaluated on a chemical-by-chemical
basis. Additional data are needed before making gener-
alized changes in experimental design.
The meeting participants reiterated and supported the
concept that in the absence ofepidemiological data, long-
term rodent studies are still currently the best available
method for evaluating a chemical's carcinogenic potential
and for extrapolating the results to humans. They agreed
with the conclusions of the International Agency for
Research on Cancer (IARC) that in the absence of ade-
quate data for humans, it is prudent to regard agents for
which there is sufficient evidence of carcinogenicity in
experimental animals as ifthey presented a carcinogenic
risk to humans. It was also recommended that in certain
instances, ancillary tests to determine mechanisms of
action or answerspecific scientific questions might also be
incorporatedintothe2-yeartests. Examplesmightinclude
"stop-start" exposure studies to evaluate progression,
regression ofinduced lesions; intermittent exposure stud-
ies; cellular proliferation studies; studies of oncogene
activation; andmeasurements ofDNAdamageandadduct
formation. Carcinogenesis is a multistage process, and,
ultimately, it is the underlying mechanism of carcino-
genesis in animals and its relevance to humans that must
be determined.
Cell Proliferation
As was mentioned previously, the role of cell prolifera-
tion in chemical carcinogenicity has been the focus of
considerable debate recently. Cell proliferation has long
been implicated as having a critical role in both the initia-
tion and promotion stages of chemically induced cancer.
Recently, however, chemically induced, sustained cell pro-
liferationhasbeenimplicated asleadingtopreneoplasiaor
neoplasia by increasing the probability of spontaneous
mutations and has been implicated as the major cause of
cancer by nongenotoxic chemicals in animal carcino-
genicitystudies(4). Contrarytothisview,cellproliferation
perseis notcarcinogenic (15).Areviewoftheliterature on
therelationship betweenchemicallyinduced cellprolifera-
tionandcarcinogenesisrevealsthatveryfewcellprolifera-
tion studies have been conducted over extended exposure
periods. Moreover, the proliferation response resulting
from exposure to many nongenotoxic carcinogens is not
well sustained, whereas the elicitation of a carcinogenic
response by these chemicals often requires a prolonged
exposure duration. Thus, adequate data are not available
to support the hypothesis that chemically induced cell
proliferation causes cancer.
The NTP has established staining techniques to iden-
tify cells undergoing replicative DNA synthesis in histo-
logic tissue sections. Using osmotic minipumps to deliver
the labeling agent bromodeoxyuridine, labeling indexes
have been measured in several studies. While a tentative
relationship between enhanced replicative DNAsynthesis
(cell proliferation) has been documented in 90-day studies
with some carcinogenic versus noncarcinogenic isomers,
these studies must be interpreted only as preliminary
evidenceofanassociationbetweenenhancedcellprolifera-
tion and carcinogenesis in rodents. In the ethyl acrylate
studies, dramatic enhanced cellproliferation sustained for
90 days is insufficient to lead to induction offorestomach
neoplasia. No enhanced cell proliferation was found in the
subchronic and chronic methylene chloride inhalation
studies, which would explain the excess liver tumors
induced bythis chemical. These results are interpreted as
evidence that factors other than sustained enhanced cell
proliferation must be invoked to explain the observed
carcinogenicity for many rodent carcinogens. It is also
apparent from these studies that a variety of biological
factors must be considered in the design, conduct, and in-
terpretation ofcellproliferation studies in rodentbioassays.
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Toxicity As a Predictor of
Carcinogenicity
There is a lack of adequate data on the relationships
between chemicallyinduced toxicity, cellproliferation, and
carcinogenicity. The analysis of 2-year carcinogenicity
studies of99 chemicals in rats and mice by Hoel et al. (11)
revealed that only 7 ofthe 53 positive animal carcinogens
showed a clear link between organ toxicity and tumor
development. Forthe other46, cancers occurredin organs
with no apparenttoxicity, andvisiblydamaged organs had
no tumors. Morerecently, NTPinvestigators found similar
results when analyzing another set ofchemicals to deter-
mine whether subchronic and chronic toxicity can predict
carcinogenicity in the same organ. Subchronic toxicity,
chronic toxicity, and carcinogenicity, with respect to site
and morphology, were reviewed from a group of31 chemi-
cals that wererecentlyevaluated by NTP. This group of31
chemicals (22 carcinogens and 9 chemicals with no evi-
dence of carcinogenicity) was chosen from studies evalu-
ated by the NTP over a specified period of time but was
otherwise not apreselected group. Inthisreview, avariety
ofsubchronic and chronic toxic lesions wereidentifiedwith
30 of these chemicals in at least 18 different organs or
tissues. The administration of both genotoxic and non-
genotoxic chemicals resulted in toxic injury at a number of
sites in which no carcinogenic response was observed.
Furthermore, for some genotoxic chemicals, carcinogenic
responses occurred at sites in which no subchronic or
chronic toxicity was observed. Although subchronic tox-
icity and subsequent carcinogenic response in the kidney
was more often seen with nongenotoxic chemicals, both
genotoxic and nongenotoxic chemicals resulted in toxicity
at a number oforgan/tissue sites inwhich no carcinogenic
response occurred.
In some instances (e.g., 1-4-dichlorobenzene), target
organ toxicity may occurwith carcinogenicity. However, it
is an oversimplification to assumethattoxicity can account
for all carcinogenicity. The many different sites and types
ofcarcinogenic effects observed, coupled with the diverse
structures of chemicals, makes it impossible to make
global statements about mechanisms of action or generic
statements about structure-activity relationships.
Mid-Term Assays
The latter half ofthe meeting was devoted to a discus-
sion of additional approaches for detecting carcinogenic
effects without conducting the conventional 2-year bio-
assay studies. A number of studies have defined distinct
stagesinthecarcinogenic process, and several experimen-
tal models have been developed in an attempt to identify
agentsthatmayaffectthese differentstages. The status of
a number of these experimental models and their useful-
ness in carcinogenicity testing were reviewed. It was
concluded that although these assays arelimited to effects
on single organs or involve administration in conjunction
with other chemical substances, they can measure the
potential contribution of the test substances to the car-
cinogenic process. Thus, they are very useful to elucidate
the mechanisms of carcinogenicity and setting priorities
for further testing needs.
Limited Screening Model Systems
The utility of the strain A mouse pulmonary tumor
assayand IVorSCinjection assayswereevaluated. Itwas
concluded (16) that the strain A results were discordant
with 2-year carcinogenicity test results for detecting car-
cinogenic activity of aromatic amines and several other
miscellaneous chemicals. Data ontheusefulness ofIVand
SC routes of exposure for detecting the carcinogenic
potential ofnitrosamines (17-19) and the ability of adria-
mycin to induce mammary tumors (20) was also pre-
sented. An analysis of the IARC Monographs has also
revealed a high concordance between distanttumors from
SC injections and distant tumors from other routes of
exposure.
Assays for Initiating and Promoting
Activities Including Early
Preneoplastic Lesions
The fate of preneoplastic lesions cannot be predicted
unequivocally and thus preneoplastic lesions alone are not
definitive indicators of carcinogenicity. The detection of
such lesions, however, may be useful for helping to eluci-
date the mechanisms of carcinogenicity, for predicting
potential target organ neoplasia, and for determining
which chemicals need more extensive testing. Putative
preneoplastic lesions in several organ systems were dis-
cussed briefly to illustrate current research efforts and
identify future research needs.
Skin
Data were presented on the initiating activities of a
variety of chemicals in the two-stage mouse skin car-
cinogenesis model (21-24) using 12-O-tetradecanoyl-
phorbol-13-acetate (TPA) as the promoter. All compounds
were topically applied twice weekly on the dorsal skin of
male mice, and then followed by similar TPA administra-
tion for 2 weeks. The compounds, 2-(2-furyl)-3-(5-nitro-2-
furyl)acrylamide (AF-2) and butylated hydroxyanisole
showed an initiating potential, but butylated hydrox-
ytoluene and quercetion did not. Nine heterocyclic amines
isolated from amino acid pyrolysates were examined simi-
larly, only Trp-P-2 was found to have an initiating action.
Liver
The liver is a target organ in more than 50% of the
chemicals so far evaluated for carcinogenicity by IARC
and the National Cancer Institute (NCI)/NTP. Therefore,
amedium-termbioassay, the dimethylnitrosamine-partial
hepatectomy (DEN-PH) model, has recently been devel-
oped inJapan to detectlivercarcinogens in a shortperiod
usingmale F344rats (25). Twoweeksafter IPadministra-
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tion ofDEN (200mg/kg), test compours are given orally
for 6 weeks; partial hepatectomy is conducted at week 3.
The animals arekilled atweek8, anduivlJiversections are
subject to the immunohistochemical stGihiing to examine
thenumberand areasofglutathione A-transferaseplacen-
tal form (GST-P)-positive foci. To date, 95% ofthe known
liver carcinogens, but only 22% of the nonliver car-
cinogens, havebeenfoundtobepositivebythismodel.The
DEN-PH model can detect both hepatocarcinogens and
chemicals having an inhibitory effect on liver car-
cinogenesis, irrespective oftheir genotoxicity, in a limited
time using a small number of animals. Observations on
altered hepatocellular foci (AHF) in conventional 2-year
NTP carcinogenicity studies also demonstrated that
hepatocarcinogens may induce unique types of AHF in
rats. Such changes are potentially useful predictors of
hepatic neoplasia (26).
Forestomach
When administered by gavage in corn oil for 2 years,
ethyl acrylate induces benign and malignant forestomach
neoplasia in both sexes ofrats and mice. The initial reac-
tion ofthe forestomach to such treatment is development
ofapronounced and persistent mucosal hyperplasia. This
has led to the postulation that the observed forestomach
carcinogenicityofethylacrylate is secondaryto sustained
enhanced cellproliferation. In arecentlycompleted study,
ethyl acrylate was given by gavage at carcinogenic doses
for 90 days, at which time there was clear evidence of
mucosal hyperplasia.Whenratswereheldwithoutfurther
treatment for an additional 19 months, the hyperplasia
completely regressed and no forestomach neoplasia was
observed. Itwas concluded thatsustained, enhanced fore-
stomach mucosal hyperplasia for 90 days was insufficient
to induce neoplasia at this target site. Additional studies
withthis chemical areunderwayto determineiftreatment
will lead to induction offorestomach neoplasia.
Pancreas
The morphogenesis ofpancreatic carcinomas has been
studied extensively in rats and hamsters. Male SD rats
were initiated with a single intravenous treatment of
4-hydroxyaminoquinoline-N-oxide (4HAQO; 7mg/kg) and
after 1 week were given soybean trypsin inhibitor (SBTI)
in the diet (5 and 10%) for 51 weeks. SBTI treatment was
found to result in a significant increase in numbers of
eosinophilic nodules and a decreased number ofbasophilic
foci. In studies on ductal cell pancreatic carcinogenesis,
male hamsters were initiated with five SC injections of
N-nitrosobis(2-oxopropyl)amine (10 mg/kg) and within 4
weeks were simultaneously given 5% SBTI in the diet.
After 26 weeks on a basal diet, the numbers of adenocar-
cinomas and dysplastic foci were significantlysuppressed.
However, the effect was muchweakerwhen the SBTI diet
was given for 37 weeks after initiation. Therefore, SBTI
showed an enhancing effect on the promotional stage of
acinar cell carcinogenesis and an inhibitory effect on the
initiating stage ofductal cell carcinogenesis.
Upper Respiratory Tract
The promoting effect of cigarette smoking was exam-
ined using the two-stage laryngo-tracheal carcinogenesis
model inhamstersfollowinginitiationbya singleinjection
of diethylnitrosamine. The incidences and numbers of
papillomasandhyperplasiasoftheupperrespiratorytract
and lung lipid peroxidation levels were significantly
increased (27).
Kidney
A dose-related enhancing effect of potassium bromate
on renal tumorigenesis in rats initiated with N-ethyl-N-
hydroxyethylnitrosamine was reported (28,29). The mean
numbers of kidney dysplastic foci were significantly
increasedinadose-relatedmannerinratstreated atdoses
higherthan30ppm; themean numberofrenal celltumors
was significantly increased at 500 ppm. Potassium bro-
mide, a degradation product, was found to be negative.
Studies on five metal compounds (Zn, Hg, Cr, Cd, Ni)
using the same two-stage renal carcinogenesis protocol
showed thatnickel chloride exerted apotential forpromo-
tion ofrenal tumorigenesis (30).
Urinary Bladder
Sodium ascorbate, sodium carbonate, and ascorbic acid
were found to act as promoters in a two-stage urinary
bladder carcinogenesis model in male rats initiated with
N-butyl-N-(4-hydroxybutyl)nitrosamine. An increased
incidence of transitional cell carcinomas was observed,
and a positive correlation was found between the levels of
pH and sodium ion in the urine and the promoting effects
ofchemicals (31-33).
Female Genital, Nervous, and
Hematopoietic Systems
Two-stage carcinogenesis assays have not been fully
established for the female genital, nervous, and hema-
topoietic systems because detection ofearlypreneoplastic
changes remains difficult, and proper enzymatic markers
showing these changes are generally lacking.
Update on National Institute of
Hygienic Sciences Activities
The results ofthe carcinogenicity tests on eight chemi-
calsrecentlyfinished atNIHSwerepresented. Dicofol, an
organochlorine pesticide structurallyrelated to DDT, was
given to male B6C3F1 mice (50/group) atvarious doses in
feed for 80weeks. The incidence ofliver tumors in groups
fed500,300,200,100,50, and 0ppmwas,respectively, 85%
(p < 0.01, 80% (p < 0.01), 71% (p < 0.01), 34%, 18%, and
25%. Histologically, mostofthetumorswere diagnosed as
hepatocellular adenomas and carcinomaswith some cases
ofhepatoblastomas and hemangiomas. The virtually safe
dose(VSD) atrisklevelof10-6was 0.191 ,ug/kg/daybythe
Weibull model.
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Sodium orthophenylphenate (OPP-Na), an antifungal
agent,wasgiven atvarious dosesinfeed tomale F344rats
(50/group) for 104 weeks. The combined incidences of
papillomas and transitional cell carcinomas oftheurinary
bladderwere significantlyincreasedin rats fed 1.5 and 2%
OPP-Na. TheVSD atrisklevel of10-6 was 147ppmin the
diet by the Weibull model.
Muskxylol, asynthetic nitromusk,was administered at
dietary levels of0.15 and 0.075% to groups of50 male and
50 female B6C3F1 mice for 80 weeks (34). Combined
incidences ofmalignant and benign liver cell tumors were
clearly increased in both sexes, and in males a positive
significant trend was also noted for the occurrence of
hepatocellular carcinomas. In males, the incidence of
Harderian gland tumors was also significantly increased.
It was concluded that musk xylol is carcinogenic in mice.
6-Mercaptopurine (6-MP), an anticancer agent, was
administered to F344 rats of both sexes (50/group) at
dietary levels of 50 and 25 ppm for 104 weeks (35). In
females, the incidence ofC-cell tumors ofthe thyroid and
pheochromocytomas ofthe adrenals in the 50 ppm group
were significantly increased. However, considering the
factthattheratesforspontaneous tumorsinthistestwere
lower than those of historical controls, it was concluded
thatthe carcinogenicity of6-MPwasveryweak ormargi-
nal.
5-Fluorouracil (5-FU), an anticancer drug,was given to
F344 rats ofboth sexes (50/group) at doses of125 and 62
ppm in the drinking water for 104 weeks. There were no
significant increases intheincidences ofanytumorswhen
compared to those ofcontrols, and itwas concluded 5-FU
was not carcinogenic in rats. However, because the max-
imumtolerateddosesusedinthesetestswereverycloseto
the clinical doses used, the true carcinogenic potential of
5-FU and 6-MP remains unknown.
Phenytoin, an anticonvulsant, was administered to
groups of 50 male and 50 female F344 rats in the diet at
doses of 0.05 and 0.25% for 104 weeks. No significant
increases were observed in the incidences ofany particu-
lar type of tumors in the treated groups of either sex. It
was concluded thatphenytoinwasnotcarcinogenic inrats.
Calcium lactate, afood additive, was given to F344 rats
of both sexes (50/group) in the drinking water at the
concentrations of 5 and 2.5% for 104 weeks (36). The rats
werekilledafteran8-weekrecoveryperiod.Therewereno
significant increases in tumor incidence related to the
treatment, and it was concluded that calcium lactate was
not carcinogenic in rats.
Monosodium succinate, afood additive, was giveninthe
drinking water at levels of2 and 1% to F344 rats ofboth
sexes (50/group) for 104 weeks, and animals were killed in
week 112 (37). Although an increase in the incidence of
C-cell tumors ofthe thyroid was found in high-dose group
females, it was probably a function of experimental vari-
ability and not related to the treatment. It was concluded
thatmonosodium succinate had nocarcinogenic activityin
rats.
The chemicals currently being tested in rats (F344 or
Wistar) at the NIHS are: 2,2,3,3,3-pentafluoi'opropanol,
2,4,5-triamino-1,3,5-triazine (Melamin); p-dichloroben-
zene; '. '-,. thylenebis-(4-methyl-6-tert-butylphenol);
diisopro '`'ez7Qne; cyclodextrin; stevioside, n-paraffin;
and potas ^ iodide.
Update on Chemical Substances
Control Act in Japan
Underthe Chemical Substances ControlAct, adoptedin
1973 and revised in 1987, new and existing chemicals have
been classified into class-1 specified chemical substances,
class-2 specified chemical substances, and designated
chemical substances based on their properties of bio-
degradation, bioaccumulation, and chronic toxicity (38).
Since the previous report (1), bis(tributyl)tin oxide has
been added to the list of class-1 specified chemical sub-
stances. The survey on the mutagenic and toxicological
profiles of 218 new chemical substances that were evalu-
ated by the Safety Evaluation Committee ofthe Ministry
ofHealth and Welfare was presented. Out ofthe 218 new
chemicals, 60 (28%)wereclassified asdesignatedchemical
substances. With respect to mutagenicity, 20 (9%) and 60
(28%) chemicals were positive in the Ames and chromo-
some aberration tests, respectively. The results ofthe 28-
day repeated dose study with a 14-day recovery period
showed thatthe liver and the kidneywere the main target
organs. In general, chemicals whose no observed effect
levels were lower than 20 mg/kg/body weight and which
showed positive mutagenic activitywere classified as des-
ignated chemical substances.
Reproductive Familiarization Study
The OECD has recently proposed a new guideline,
"Combined Repeat Dose and Reproductive/Development
Toxicity Screening Test (Repro/Tox)," for rapid screening
ofhigh-production-volume chemicals (39). NIHSscientists
have become familiarized with this novel and unique pro-
tocol, designed to detect general toxicological effects
simultaneously with reproductive/developmental effects.
Studies were conducted on cyclosphosphamide (CP),
selected as a reference compound, according to the test
guideline. As a result, most of the known systemic and
reproductive/developmental toxicological effects of CP
were demonstrated bythis test. Therefore, Repro/Tox can
be considered as a useful rapid screening test for high-
production-volume chemicals (40).
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